Evidence map›Paper›PMID 41669303›Full record

ArticleAdvanced biomedical research2025

Comparing the Impact of Metoclopramide versus Ondansetron on Pain Reduction Caused by Etomidate Injection in Patients under General Anesthesia.

Zahra Rahimi, Behzad Nazemroaya, Mehrdad Masoudifar, Nazanin Nazari

Abstract read
In one paragraph

Article in Advanced biomedical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zahra RahimiDepartment of Anesthesiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Behzad NazemroayaDepartment of Anesthesiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Mehrdad MasoudifarDepartment of Anesthesiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Nazanin NazariDepartment of Anesthesiology and Critical Care, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Etomidate is a short-acting intravenous anesthetic commonly used for induction of general anesthesia and sedation. Preventing pain caused by etomidate injection can improve patient comfort and broaden its clinical use. This study compared the effects of metoclopramide and ondansetron on etomidate injection-related pain in patients undergoing general anesthesia. Materials and Methods: In this randomized clinical trial conducted at Al-Zahra Hospital, Isfahan, from 2021 to 2022, 90 patients were randomly assigned to three groups ( Results: The control group exhibited a higher mean pain score than the intervention groups. Pain intensity differed significantly between the metoclopramide and control groups ( Conclusion: Both metoclopramide and ondansetron attenuate pain associated with etomidate injection during induction of general anesthesia, with no clear superiority of one drug over the other. Their comparable efficacy supports either as an appropriate option for preventing etomidate-related pain.

Indexed as

Etomidatemetoclopramideondansetronpain

Identifiers

PMID41669303
PMCPMC12885201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.